Exhibit 16.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
November 7, 2022
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Re: Quoin Pharmaceuticals, LTD
Commission File Number 001-37846
Commissioners:
We have read the statements made by Quoin Pharmaceuticals, LTD of its Form 6-K dated November 7, 2022. We agree with the statements concerning our firm in such Form 6-K; we are not in a position to agree or disagree with other statements contained therein.
Very truly yours,
/s/ Friedman LLP
East Hanover, New Jersey
